A Randomized, Controlled Trial of the Pan-PPAR Agonist Lanifibranor in NASH

Author:

Francque Sven M.1ORCID,Bedossa Pierre1,Ratziu Vlad1,Anstee Quentin M.1,Bugianesi Elisabetta1,Sanyal Arun J.1,Loomba Rohit1,Harrison Stephen A.1,Balabanska Rozalina1,Mateva Lyudmila1,Lanthier Nicolas1ORCID,Alkhouri Naim1,Moreno Christophe1,Schattenberg Jörn M.1ORCID,Stefanova-Petrova Diana1,Vonghia Luisa1,Rouzier Régine1,Guillaume Maeva1,Hodge Alexander1,Romero-Gómez Manuel1,Huot-Marchand Philippe1,Baudin Martine1,Richard Marie-Paule1,Abitbol Jean-Louis1,Broqua Pierre1,Junien Jean-Louis1,Abdelmalek Manal F.1

Affiliation:

1. From Antwerp University Hospital and the Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp (S.M.F., L.V.), and Service d’Hépato-Gastroentérologie, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain (N.L.) and Cliniques Universitaires de Bruxelles–Hôpital Erasme, Université Libre de Bruxelles (C.M.), Brussels — all in Belgium; the Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom (P....

Funder

Inventiva Pharma S.A., Daix, France

Publisher

Massachusetts Medical Society

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3